학술논문
1121P Real-world (RW) data from the sotorasib French pre-market authorization early access program in patients (pts) with KRASG12C driven metastatic non-small cell lung cancer (mNSCLC): Clinical characteristics
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S1063-S1064
Subject
Language
ISSN
0923-7534